OrbiMed’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

OrbiMed’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100,000	Closed	-$350K	–	161
2018 Q1	$350K	Hold	100,000	–	–	﹤0.01%	139
2017 Q4	$312K	Hold	100,000	–	–	﹤0.01%	131
2017 Q3	$703K	Hold	100,000	–	–	0.01%	135
2017 Q2	$923K	Hold	100,000	–	–	0.01%	130
2017 Q1	$1.07M	Hold	100,000	–	–	0.01%	128
2016 Q4	$842K	Buy	+100,000	New	+$886K	0.01%	125

Other funds holding NVLN

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return